Clinical Trials Logo

Clinical Trial Summary

The purpose of this study will evaluate new technologies that have been included in the new PCA-9000A PET/CT System.


Clinical Trial Description

Scope:

To evaluate the new technologies that have been included in the PCA-9000A PET/CT System, the study has the following 3 goals.

- Define and confirm all supported clinical protocols from Low-Dose CT, to PET acquisition and presentation.

- Verification of the quantitative accuracy of the imaging chain.

- Evaluate the performance and stability of the new system and its related quality control and calibration procedures.

Result (Expected):

The study is an essential step in assessing the quality of the hardware and software defining the new PCA-9000A PET/CT System. Several essential parameters for the acquisition, reconstruction, correction, filtering, and presentation will be estimated or adjusted during this period. The evaluation will confirm PCA-9000A PET/CT System is effective for its intended use. ;


Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms

  • Confirm PCA-9000A PET/CT System is Effective for Its Intended Use

NCT number NCT01701167
Study type Observational
Source Toshiba America Medical Systems, Inc.
Contact
Status Not yet recruiting
Phase N/A
Start date November 2012